APR Applied Pharma Research SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:APR Applied Pharma Research SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3039
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
APR Applied Pharma Research SA (APR) is a healthcare product developer and distributor. The company research, develops, and licenses technology and clinically proven prescription pharmaceuticals. It offers consumer health products, prescription healthcare products and therapeutic products. APR’s product pipeline portfolio includes nexodyn, gemiax, exelya, APR 1301-01, APR 1203-01 and APR 1204. The company offers services such as oral formulations, tropical formulations and analytical services. It develops products for various therapeutic areas including cancer, dermatology, genetic metabolic diseases, pain management and tissue transplantation APR is headquartered in Balerna, Switzerland.

APR Applied Pharma Research SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
APR Applied Pharma Research SA, Medical Devices Deals, 2012 to YTD 2018 9
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
APR Applied Pharma Research Raises Funds through Venture Financing 11
Private Equity 12
HBM Partners Acquires Minority Stake in APR Applied Pharma 12
Partnerships 13
APR Applied Pharma Research Enter into Distribution Agreement with Aghraas-Cigalah 13
Fidia Farmaceutici Enters into Agreement with APR Applied Pharma Research 14
Licensing Agreements 15
Mundipharma Enters into Licensing Agreement with APR Applied Pharma Research 15
Renhe Enters into Licensing Agreement with APR Applied Pharma Research for Diclofenac Powder 16
APR Applied Pharma Research And Labtec Enter Into Licensing Agreement With Norgine For Setofilm 17
Eris Pharma Enters into Licensing Agreement with APR Applied Pharma Research 18
APR Applied Pharma Enters into Licensing Agreement with Amicus 19
Angelini Enters Into Licensing Agreement With APR Applied Pharma 20
APR Applied Pharma Research SA – Key Competitors 21
APR Applied Pharma Research SA – Key Employees 22
APR Applied Pharma Research SA – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Product News 24
Sep 05, 2017: PKU: Pre-Clinical Kinetic Data Showing Prolonged Release of Amino Acids Thanks to the Innovative Physiomimic Technology by APR Presented at the 13th ICIEM Congress (September 5th-8th, Rio de Janeiro) 24
Apr 06, 2017: APR Applied Pharma Research Wants to Make the Difference for PKU People Thanks to an Innovative and Patented Technology 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Key Facts 2
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
APR Applied Pharma Research SA, Deals By Therapy Area, 2012 to YTD 2018 8
APR Applied Pharma Research SA, Medical Devices Deals, 2012 to YTD 2018 9
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
APR Applied Pharma Research Raises Funds through Venture Financing 11
HBM Partners Acquires Minority Stake in APR Applied Pharma 12
APR Applied Pharma Research Enter into Distribution Agreement with Aghraas-Cigalah 13
Fidia Farmaceutici Enters into Agreement with APR Applied Pharma Research 14
Mundipharma Enters into Licensing Agreement with APR Applied Pharma Research 15
Renhe Enters into Licensing Agreement with APR Applied Pharma Research for Diclofenac Powder 16
APR Applied Pharma Research And Labtec Enter Into Licensing Agreement With Norgine For Setofilm 17
Eris Pharma Enters into Licensing Agreement with APR Applied Pharma Research 18
APR Applied Pharma Enters into Licensing Agreement with Amicus 19
Angelini Enters Into Licensing Agreement With APR Applied Pharma 20
APR Applied Pharma Research SA, Key Competitors 21
APR Applied Pharma Research SA, Key Employees 22

List of Figures
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
APR Applied Pharma Research SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[APR Applied Pharma Research SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wm Morrison Supermarkets PLC:企業のM&A・事業提携・投資動向
    Wm Morrison Supermarkets PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wm Morrison Supermarkets PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Globavir Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Globavir Biosciences Inc (Globavir) is a biotechnology company that develop combination of drug therapies and diagnostic tests in the therapeutic areas of infection and immune-oncology. The company develops Globavir’s Drug Discovery Platform (GDDP), which generates small molecule candidates …
  • Xbrane Biopharma AB (XBRANE):企業の財務・戦略的SWOT分析
    Summary Xbrane Biopharma AB (Xbrane), formerly Xbrane Bioscience AB is a biopharmaceutical company that develops and manufactures complex generic products . The company's product portfolio includes biosimilars and long acting injectables developed for people suffering from critical diseases. It comb …
  • Cancer Genetics Inc (CGIX):製薬・医療:M&Aディール及び事業提携情報
    Summary Cancer Genetics Inc (CGI) is a pharmaceutical company that provides diagnostics products and services in oncology areas. The company offers products such as CGH microarrays, next-generation sequencing and DNA-FISH Probes. Its oncology tests and laboratory services offer critical genomic info …
  • Mayne Pharma Group Ltd (MYX)-製薬・医療分野:企業M&A・提携分析
    Summary Mayne Pharma Group Ltd (Mayne Pharma), formerly Mayne Pharma International Pty Ltd, a subsidiary of Hospira Inc, is a specialty pharmaceutical company that manufactures and markets branded and generic medicinal products. The company’s products comprise astrix capsules and tablets, erymax cap …
  • DocCheck AG (AJ91):企業の財務・戦略的SWOT分析
    DocCheck AG (AJ91) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • BioInvent International AB (BINV):企業の財務・戦略的SWOT分析
    BioInvent International AB (BINV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Ra Medical Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Ra Medical Systems Inc (Ra Medical Systems) is a medical device company that develops, designs, and commercializes excimer laser systems for the treatment of cardiovascular and dermatologic diseases. The company’s technology provides operational versatility and dose customization. Its produc …
  • Canacol Energy Ltd (CNE):企業の財務・戦略的SWOT分析
    Summary Canacol Energy Ltd (Canacol Energy) is an oil and gas company that explores and produces conventional and unconventional oil fields. The company operates oil and gas reserves in Caguan-Putumayo basin, Lower Magdalena basin, Llanos basin, Magdalena basin in Colombia; and Oriente basin in Ecua …
  • Bilfinger SE (GBF):石油・ガス:M&Aディール及び事業提携情報
    Summary Bilfinger SE (Bilfinger) is a provider of industrial engineering services. It offers a wide range of services from consulting, construction, manufacturing, plant expansion to maintenance and project management services across diverse end markets. The company’s major service offerings include …
  • Vilniaus Degtine AB:企業の戦略・SWOT・財務情報
    Vilniaus Degtine AB - Strategy, SWOT and Corporate Finance Report Summary Vilniaus Degtine AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Anglo American Plc:企業のM&A・事業提携・投資動向
    Anglo American Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Anglo American Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Harmonic Inc (HLIT):企業の財務・戦略的SWOT分析
    Harmonic Inc (HLIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Nectar Lifesciences Ltd (NECLIFE):企業の財務・戦略的SWOT分析
    Summary Nectar Lifesciences Ltd (NecLife) is a research driven pharmaceutical company that manufactures active pharmaceutical ingredients (APIs). The company provides contract research and manufacturing services such as process development and optimization, process scale up and validation, multi kil …
  • Laurus Labs Ltd (LAURUSLABS):製薬・医療:M&Aディール及び事業提携情報
    Summary Laurus Labs Ltd (Laurus Labs) is a drug development company that manufactures active pharmaceutical ingredients. The company develops products through its business divisions such as laurus generics, ingredients and synthesis. It offers active pharmaceutical ingredients and intermediates for …
  • Tosoh Corp (4042):企業の財務・戦略的SWOT分析
    Tosoh Corp (4042) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sequella Inc:医療機器:M&Aディール及び事業提携情報
    Summary Sequella Inc (Sequella) is a clinical-stage pharma company that develops antibiotics to address drug resistant bacterial, fungal, and parasitic infections. The company’s pipeline products comprise SQ109, Sutezolid, SQ641 and SQ609; and a novel rapid antibiotic susceptibility test, B-SMART. S …
  • Oglethorpe Power Corporation:電力:M&Aディール及び事業提携情報
    Summary Oglethorpe Power Corporation (Oglethorpe) is a member-owned non-profit electric utility that provides wholesale electric power to retail electric distribution cooperative members. The cooperative operates through a diverse portfolio of owned and leased power supply resources utilizing natura …
  • Meggitt Training Systems, Inc.:企業の戦略・SWOT・財務分析
    Meggitt Training Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Meggitt Training Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Daechang Forging Co Ltd:企業の戦略・SWOT・財務分析
    Daechang Forging Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Daechang Forging Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆